WallStSmart
CMMB

Chemomab Therapeutics Ltd DRC

NASDAQ: CMMB · HEALTHCARE · BIOTECHNOLOGY

$1.47
+0.68% today

Updated 2026-04-30

Market cap
$11.59M
P/E ratio
P/S ratio
EPS (TTM)
$-1.44
Dividend yield
52W range
$1 – $6
Volume
0.1M

Chemomab Therapeutics Ltd DRC (CMMB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+84.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+62.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+6.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+9.1%
2025-12-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.00+70.0%$1.64$1.79+9.1%
2025-11-07$-0.00+20.0%$2.58$2.70+4.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.01$-0.00+70.0%
2025-09-30$-0.01$-0.00+20.0%
2025-06-30$-0.10$-0.02+84.0%
2025-03-31$-0.01$-0.01+30.0%
2024-12-31$-0.01$-0.01+20.0%
2024-09-30$-0.01$-0.01+0.0%
2024-06-30$-0.01$-0.26-2500.0%
2024-03-31$-0.03$-0.28-817.7%
2023-12-31$-0.02$-0.27-1227.0%
2023-09-30$-0.02$-0.02+0.0%
2023-06-30$-0.03$-0.04-20.0%
2023-03-31$-0.04$-0.80-1900.0%

Frequently asked questions

Has Chemomab Therapeutics Ltd DRC beaten earnings estimates?
Chemomab Therapeutics Ltd DRC has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +84.0% over the last 1 quarters.
How does CMMB stock react to earnings?
CMMB stock has moved an average of +6.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.